Discovery and SAR study of c-Met kinase inhibitors bearing an 3-amino-benzo[d]isoxazole or 3-aminoindazole scaffold

Bioorganic and Medicinal Chemistry

Volumn 23, Issue 3, 2015, Pages 564-578

  Jiang, Xiaolong ^a   Liu, Hongyan ^b   Song, Zilan ^c   Peng, Xia ^b   Ji, Yinchun ^b   Yao, Qizheng ^a   Geng, Meiyu ^b   Ai, Jing ^b   Zhang, Ao ^c  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^c SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

3 Amino benzo d isoxazole; 3 Aminoindazole; c Met kinase; Inhibitor; Non small cell lung cancer

Indexed keywords

3 AMINO BENZO[D]ISOXAZOLE; 3 AMINOINDAZOLE; AGENTS AFFECTING METABOLISM; ANTIMITOTIC AGENT; ENZYME INHIBITOR; FUSED CARBON NITROGEN HETEROCYCLE; ISOXAZOLE; N [3 [(3 AMINOBENZO[D]ISOXAZOL 4 YL)OXY]PHENYL] N (4 FLUOROPHENYL)CYCLOPROPANE 1,1 DICARBOXAMIDE; N [4 (3 AMINOBENZO[D]ISOXAZOL 4 YL) 3 FLUOROPHENYL] N (4 FLUOROPHENYL)CYCLOPROPANE 1,1 DICARBOXAMIDE; N [4 (3 AMINOBENZO[D]ISOXAZOL 4 YL)PHENYL] N (2,4 DIFLUOROPHENYL)CYCLOPROPANE 1,1 DICARBOXAMIDE; N [4 (3 AMINOBENZO[D]ISOXAZOL 4 YL)PHENYL] N (3 CHLORO 4 FLUOROPHENYL)CYCLOPROPANE 1,1 DICARBOXAMIDE; N [4 (3 AMINOBENZO[D]ISOXAZOL 4 YL)PHENYL] N (3 FLUOROPHENYL)CYCLOPROPANE 1,1 DICARBOXAMIDE; N [4 (3 AMINOBENZO[D]ISOXAZOL 4 YL)PHENYL] N (3,4 DIFLUOROPHENYL)CYCLOPROPANE 1,1 DICARBOXAMIDE; N [4 (3 AMINOBENZO[D]ISOXAZOL 4 YL)PHENYL] N (3,4,5 TRIMETHOXYPHENYL)CYCLOPROPANE 1,1 DICARBOXAMIDE; N [4 (3 AMINOBENZO[D]ISOXAZOL 4 YL)PHENYL] N (4 CHLOROPHENYL)CYCLOPROPANE 1,1 DICARBOXAMIDE; N [4 (3 AMINOBENZO[D]ISOXAZOL 4 YL)PHENYL] N (4 FLUOROPHENYL)CYCLOPROPANE 1,1 DICARBOXAMIDE; N [4 (3 AMINOBENZO[D]ISOXAZOL 4 YL)PHENYL] N (4 TOLYL)CYCLOPROPANE 1,1 DICARBOXAMIDE; N [4 (3 AMINOBENZO[D]ISOXAZOL 4 YL)PHENYL] N (4-FLUORO 3 METHOXYPHENYL)CYCLOPROPANE 1,1 DICARBOXAMIDE; N [4 (3 AMINOBENZO[D]ISOXAZOL 4 YL)PHENYL] N [3 FLUORO 4 (4 METHYLPIPERAZIN 1 YL)PHENYL]CYCLOPROPANE 1,1 DICARBOXAMIDE; N [4 (3 AMINOBENZO[D]ISOXAZOL 4 YL)PHENYL] N [4 (1 METHYL 1H PYRAZOL 4 YL)PHENYL]CYCLOPROPANE 1,1 DICARBOXAMIDE; N [4 (3 AMINOBENZO[D]ISOXAZOL 4 YL)PHENYL] N [4 (1 METHYL 1H PYRAZOL 5 YL)PHENYL]CYCLOPROPANE 1,1 DICARBOXAMIDE; N [4 (3 AMINOBENZO[D]ISOXAZOL 4 YL)PHENYL] N [4 (TRIFLUOROMETHYL)PHENYL]CYCLOPROPANE 1,1 DICARBOXAMIDE; N [4 (3 AMINOBENZO[D]ISOXAZOL 4 YL)PHENYL] N [4 CHLORO 3 [(4 METHYLPIPERAZIN 1 YL)METHYL] PHENYL]CYCLOPROPANE 1,1 DICARBOXAMIDE; N [4 (3 AMINOBENZO[D]ISOXAZOL 4 YL)PHENYL] N [4 [1 (PIPERIDIN 4 YL) 1H PYRAZOL 4 YL]PHENYL]CYCLOPROPANE 1,1 DICARBOXAMIDE; N [4 (3 AMINOBENZO[D]ISOXAZOL 4 YL)PHENYL] N [4 [1 (TETRAHYDRO 2H PYRAN 4 YL) 1H PYRAZOL 4 YL]PHENYL]CYCLOPROPANE 1,1 DICARBOXAMIDE; N [4 (5 ACETYLTHIOPHEN 2 YL)PHENYL] N [4 (3 AMINOBENZO[D]ISOXAZOL 4 YL)PHENYL]CYCLOPROPANE 1,1 DICARBOXAMIDE; N [4 [(3 AMINOBENZO[D]ISOXAZOL 4 YL)OXY]PHENYL] N (4 FLUOROPHENYL)CYCLOPROPANE 1,1 DICARBOXAMIDE; N1 [4 (3 AMINOBENZO[D]ISOXAZOL 4 YL)PHENYL] N3 (4 FLUOROPHENYL)MALONAMIDE; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; ISOXAZOLE DERIVATIVE; PROTEIN KINASE INHIBITOR;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; DRUG DESIGN; DRUG DETERMINATION; DRUG MECHANISM; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; HYDROGEN BOND; IC50; MOLECULAR DOCKING; MOLECULAR DYNAMICS; PROCESS OPTIMIZATION; STRUCTURE ACTIVITY RELATION; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DRUG DEVELOPMENT;

DRUG DISCOVERY; ISOXAZOLES; MOLECULAR DOCKING SIMULATION; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-MET; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84921371030     PISSN: 09680896     EISSN: 14643391     Source Type: Journal    
DOI: 10.1016/j.bmc.2014.12.002     Document Type: Article

References (48)

1. L. Trusolino, and P.M. Comoglio Nat. Rev. Cancer 2 2002 289
2. C. Birchmeier, W. Birchmeier, E. Gherardi, and G.F. Vande Woude Nat. Rev. Mol. Cell Biol. 4 2003 915
3. S. Rong, S. Segal, M. Anver, J.H. Resau, and G.F. Vande Woude Proc. Natl. Acad. Sci. U.S.A. 91 1994 4731
4. S. Bellusci, G. Moens, G. Gaudino, P. Comoglio, T. Nakamura, J.P. Thiery, and J. Jouanneau Oncogene 9 1994 1091
5. M. Jeffers, S. Rong, M. Anver, and G.F. Vande Woude Oncogene 13 1996 853
6. H. Takayama, W.J. LaRochelle, R. Sharp, T. Otsuka, P. Kriebel, M. Anver, S.A. Aaronson, and G. Merlino Proc. Natl. Acad. Sci. U.S.A. 94 1997 701
7. T. Otsuka, H. Takayama, R. Sharp, G. Celli, W.J. LaRochelle, D.P. Bottaro, N. Ellmore, W. Vieira, J.W. Owens, M. Anver, and G. Merlino Cancer Res. 58 1998 5157
8. J.A. Aguirre Ghiso, D.F. Alonso, E.F. Farías, D.E. Gomez, and E.B. de Kier Joffè Eur. J. Biochem. 263 1999 295
9. C. Parr, G. Watkins, R.E. Mansel, and W.G. Jiang Clin. Cancer Res. 10 2004 202
10. L. Trusolino, A. Bertotti, and P.M. Comoglio Nat. Rev. Mol. Cell Biol. 11 2010 834
11. K.H. Jung, B.H. Park, and S.S. Hong Arch. Pharm. Res. 35 2012 595
12. S.L. Organ, and M.-S. Tsao Ther. Adv. Med. Oncol. 3 2011 S7
13. J.J. Cui Expert Opin. Ther. Pat. 17 2007 1035
14. P.M. Comoglio, S. Giordano, and L. Trusolino Nat. Rev. Drug Disc. 7 2008 504
15. X. Liu, W. Yao, R.C. Newton, and P.A. Scherle Expert Opin. Invest. Drugs 17 2008 997
16. O. Abidoye, N. Murukurthy, and R. Salgia Rev. Recent Clin. Trials 2 2007 143
17. J.P. Eder, G.F. Vande Woude, S.A. Boerner, and P.M. LoRusso Clin. Cancer Res. 15 2009 2207
18. K. Zhu, X. Kong, D. Zhao, Z. Liang, and C. Luo Expert Opin. Ther. Pat. 24 2014 217
19. J.J. Cui J. Med. Chem. 57 2014 4427
20. I. Dussault, and S.F. Bellon Anticancer Agents Med. Chem. 9 2009 221
21. J. Porter Expert Opin. Ther. Pat. 20 2010 159
22. T.L. Underiner, T. Herbertz, and S.J. Miknyoczki Anticancer Agents Med. Chem. 10 2010 7
23. X. Liu, R.C. Newton, and P.A. Scherle Trends Mol. Med. 16 2010 37
24. F. Cecchi, D.C. Rabe, and D.P. Bottaro Eur. J. Cancer 46 2010 1260
25. S. Berthou, D.M. Aebersold, L.S. Schmidt, D. Stroka, C. Heigl, B. Streit, D. Stalder, G. Gruber, C.X. Liang, A.R. Howlett, D. Candinas, R.H. Greiner, K.E. Lipson, and Y. Zimmer Oncogene 23 2004 5387
26. M.H. Norman, L.B. Liu, M. Lee, N. Xi, I. Fellows, N.D. D'Angelo, C. Dominguez, K. Rex, S.F. Bellon, T.S. Kim, and I. Dussault J. Med. Chem. 2012 1858 55
27. C. Basilico, S. Pennacchietti, E. Vigna, C. Chiriaco, S. Arena, A. Bardelli, D. Valdembri, G. Serini, and P. Michieli Clin. Cancer Res. 19 2013 2381
28. P. Michieli, and F. Di Nicolantonio Nat. Rev. Clin. Oncol. 10 2013 372
29. W.Y. Hu, B. Hirakawa, B. Jessen, M. Lee, and S. Aguirre J. Appl. Toxicol. 32 2012 1008
30. R. Katayama, A. Aoyama, T. Yamori, J. Qi, T. Oh-hara, Y. Song, J.A. Engelman, and N. Fujita Cancer Res. 73 2013 3087
31. F.M. Yakes, J. Chen, J. Tan, K. Yamaguchi, Y.C. Shi, P.W. Yu, F. Qian, F.L. Chu, F. Bentzien, B. Cancilla, J. Orf, A. You, A.D. Laird, S. Engst, L. Lee, J. Lesch, Y.C. Chou, and A.H. Joly Mol. Cancer Ther. 10 2011 2298
32. R. Elisei, M.J. Schlumberger, S.P. Müller, P. Schöffski, M.S. Brose, M.H. Shah, L. Licitra, B. Jarzab, V. Medvedev, M.C. Kreissl, B. Niederle, E.E.W. Cohen, L.J. Wirth, H. Ali, C. Hessel, Y. Yaron, D. Ball, B. Nelkin, and S.I. Sherman J. Clin. Oncol. 31 2013 3639
33. D. Viola, V. Cappagli, and R. Elisei Future Oncol. 9 2013 1083
34. Z. Ji, A.A. Ahmed, D.H. Albert, J.J. Bouska, P.F. Bousquet, G.A. Cunha, G. Diaz, K.B. Glaser, J. Guo, C.M. Harris, J. Li, P.A. Marcotte, M.D. Moskey, T. Oie, L. Pease, N.B. Soni, K.D. Stewart, S.K. Davidsen, and M.R. Michaelides J. Med. Chem. 51 2008 1231
35. Y. Dai, K. Hartandi, Z. Ji, A.A. Ahmed, D.H. Albert, J.L. Bauch, J.J. Bouska, P.F. Bousquet, G.A. Cunha, K.B. Glaser, C.M. Harris, D. Hickman, J. Guo, J. Li, P.A. Marcotte, K.C. Marsh, M.D. Moskey, R.L. Martin, A.M. Olson, D.J. Osterling, L.J. Pease, N.B. Soni, K.D. Stewart, V.S. Stoll, P. Tapang, D.R. Reuter, S.K. Davidsen, and M.R. Michaelides J. Med. Chem. 50 2007 1584
36. Z. Zhao, H. Wu, L. Wang, Y. Liu, S. Knapp, Q. Liu, and N.S. Gray ACS Chem. Biol. 9 2014 1230
37. D.H. Wang, J.K. Riley, S.P. Fillery, M.F. Durstock, R.A. Vaia, and L.-S. Tan J. Polym. Sci. Part A: Polym. Chem. 51 2013 4998
38. A. Zhao, X. Gao, Y. Wang, J. Ai, Y. Wang, Y. Chen, M. Geng, and A. Zhang Bioorg. Med. Chem. 19 2011 3906
39. M.H. Potashman, J. Bready, A. Coxon, T.M. DeMelfi, L. DiPietro, N. Doerr, D. Elbaum, J. Estrada, P. Gallan, J. Germain, Y. Gu, J.C. Harmange, S.A. Kaufman, R. Kendall, J.L. Kim, G.N. Kumar, A.M. Long, S. Neervannan, V.F. Patel, A. Polverino, P. Rose, S. van der Plas, D. Whittington, R. Zanon, and H.L. Zhao J. Med. Chem. 50 2007 4351
40. K. Wu, J. Ai, Q. Liu, T.T. Chen, A. Zhao, X. Peng, Y. Wang, Y. Ji, Q. Yao, Y. Xu, M. Geng, and A. Zhang Bioorg. Med. Chem. Lett. 22 2012 6368
41. J.J. Cui, M. Tran-Dubé, H. Shen, M. Nambu, P.-P. Kung, M. Pairish, L. Jia, J. Meng, L. Funk, I. Botrous, M. McTigue, N. Grodsky, K. Ryan, E. Padrique, G. Alton, S. Timofeevski, S. Yamazaki, Q. Li, H. Zou, J. Christensen, B. Mroczkowski, S. Bender, R.S. Kania, and M.P. Edwards J. Med. Chem. 54 2011 6342
42. Lauffer, D.; Li, P.; Mcginty, K.; Ronkin, S.; Tang, Q.; Grillot, A.-L.; Waal, N., PCT Int. Appl. WO2010048131A1, 2010.
43. D. Qiu, S. Wang, S. Tang, H. Meng, L. Jin, F. Mo, Y. Zhang, and J. Wang J. Org. Chem. 2014 1979 79
44. Marcin, L., R.; Thompson, L., A., III; Boy, K., M.; Guernon, J., M.; Higgins, M., A.; Shi, J.; Wu, Y.-J.; Zhang, Y.; Macor, J., E., PCT Int. Appl. WO2010083141A1, 2010.
45. H. Li, Y. Liu, J. Liu, and Z. Liu Chem. Commun. 2011 8169
46. Y. Wang, J. Ai, Y. Wang, Y. Chen, L. Wang, G. Liu, M. Geng, and A. Zhang J. Med. Chem. 54 2011 2127
47. Z. Liu, J. Ai, X. Peng, Z. Song, K. Wu, J. Zhang, Q. Yao, Y. Chen, Y. Ji, Y. Yang, M. Geng, and A. Zhang ACS Med. Chem. Lett. 5 2014 304
48. F. Qian, S. Engst, K. Yamaguchi, P. Yu, K.A. Won, L. Mock, T. Lou, J. Tan, C. Li, D. Tam, J. Lougheed, F.M. Yakes, F. Bentzien, W. Xu, T. Zaks, R. Wooster, J. Greshock, and A.H. Joly Cancer Res. 69 2009 8009